Patients With Diabetes Don't Wear Custom Footwear Enough

Share this article:
Patients With Diabetes Don't Wear Custom Footwear Enough
Patients With Diabetes Don't Wear Custom Footwear Enough

Adherence rates for wearing custom-made footwear are inadequate for patients with diabetes with a recently healed plantar foot ulcer, according to a study published online  in Diabetes Care.

Roelof Waaijman, from the University of Amsterdam, and colleagues assessed footwear use over seven days with a shoe-worn, temperature-based monitor in 107 patients with diabetes, neuropathy, a recently healed plantar foot ulcer, and custom-made footwear. An ankle-worn activity monitor simultaneously measured daily step count; adherence was evaluated based on the percentage of steps for which prescription footwear was worn.

The researchers found that mean adherence was 71%, with 61% adherence at home, over 3,959, and 87% adherence away from home, over 2,604 steps. The mean adherence at home was 28% for 35 patients with low adherence (less than 60%). Factors which were significantly correlated with adherence included lower body mass index, more severe foot deformity, and more appealing footwear.

"This low adherence is a major threat for reulceration in this high-risk patient group," the authors wrote. "Improvement of adherence could therefore include the prescription of specific protective footwear for indoors, while the importance of wearing prescription footwear should be further promoted."

Share this article:
You must be a registered member of RUN to post a comment.

More in Diabetes

High-Fat Dairy Reduces Type 2 Diabetes Risk

High-Fat Dairy Reduces Type 2 Diabetes Risk

High meat intake, regardless of fat content, is associated with increased risk of type 2 diabetes.

Statins Provide Microvascular Benefit for Diabetics

Statins Provide Microvascular Benefit for Diabetics

Statin users with diabetes at lower risk of neuropathy, retinopathy, gangrene.

Prognostic Model Developed for Major Diabetes Outcomes

Prognostic Model Developed for Major Diabetes Outcomes

Model has adequate discrimination; has been validated in three independent cohorts.